资讯

First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...
News Medical on MSN6 个月
Innovative ALS study receives $22 million grant for experimental drug
MediciNova will provide ibudilast, an anti-inflammatory drug, currently used in Japan. The drug's ability to penetrate the ...